ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 629

Salivary Gland Ultrasonography As an Useful Tool to Distinguish Patients with Sjögren’s Syndrome at Risk for Non-Hodgkin’s Lymphoma Development

Chiara Baldini1, Nicoletta Luciano1, Francesco Ferro1, Chiara Stagnaro1, Daniela Martini1, Marta Mosca2 and Stefano Bombardieri1, 1Rheumatology Unit, University of Pisa, Italy, Pisa, Italy, 2University of Pisa, Pisa, Italy

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: salivary gland and ultrasonography, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Sjögren's Syndrome Poster I: Clinical Insights into Sjögren's Syndrome

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Salivary gland ultrasonography has been proposed as a promising novel tool for the diagnosis of primary Sjögren’s syndrome (SS).  An increasing number of studies have shown strong correlations between parenchymal inhomogeneity and disease histological and serological features.  However, the correlation between abnormal findings at the salivary gland ultrasonography and traditional risk factors for lymphoma development has not been explored, yet. Aim of this study was to evaluate whether potential abnormalities at the salivary gland ultrasonography might be correlated to any of the traditional histological and serological risk factors for lymphoma development in order to assess the role of salivary gland ultrasonography in the prognostic stratification of primary SS patients.

Methods: Patients with SS (AECG 2002) and different disease duration were consecutively enrolled in this study and systematically evaluated for traditional risk factors for lymphoma (current or past history). Salivary gland ultrasonography was performed by using a Logic 9 system. A simplified scoring system based on parenchymal inhomogeneity (ranging from grade 0 to grade 4) was adopted to assess major salivary gland involvement on the ultrasound. A grade ≥2 was considered as pathological.

Results: We included in the study 127 patients with SS (mean age = 57±5 yrs; disease duration= 14±7 yrs). The mean ultrasonographic score of the overall population was 2.5±2.3 (range 0-8). Seventy-nine patients (62.2%) presented a moderate to severe parenchymal inhomogeneity (i.e ultrasonographic score ≥2). A significantly higher mean ultrasonographic score was detected in patients with history of purpura (4.5±2.7 vs 2.4±2.3, p=0.01), salivary gland enlargement (4.3±1.9 vs 1.8±2.0, p<0.001), positivity for cryoglobulins (5.52±1.8 vs 2.4±2.3, p=0.008), and presence of  germinal center in the minor salivary gland biopsy (3.9±2.3 vs 1.6±2.1, p<0.001).The overall ultrasonographic score directly correlated with the IgG levels (r=0.384, p=0.000) and inversely with both C4 levels (r= -0.207, p=0.000) and lymphocytes count (r=-232, p=0.01). 

Conclusion: This study suggested that salivary gland ultrasonography may represent a non invasive additional tool to be used in clinical practice for the prognostic stratification of patients with SS and, specifically to distinguish those patients at higher risk for lymphoma development.


Disclosure: C. Baldini, None; N. Luciano, None; F. Ferro, None; C. Stagnaro, None; D. Martini, None; M. Mosca, None; S. Bombardieri, None.

To cite this abstract in AMA style:

Baldini C, Luciano N, Ferro F, Stagnaro C, Martini D, Mosca M, Bombardieri S. Salivary Gland Ultrasonography As an Useful Tool to Distinguish Patients with Sjögren’s Syndrome at Risk for Non-Hodgkin’s Lymphoma Development [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/salivary-gland-ultrasonography-as-an-useful-tool-to-distinguish-patients-with-sjogrens-syndrome-at-risk-for-non-hodgkins-lymphoma-development/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/salivary-gland-ultrasonography-as-an-useful-tool-to-distinguish-patients-with-sjogrens-syndrome-at-risk-for-non-hodgkins-lymphoma-development/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology